NDC11 00591350904
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00591-3509-04 | 00591-3509 |
| 00591-3509-4 | 00591-3509 |
| 0591-3509-04 | 0591-3509 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clonidine transdermal system | CLONIDINE | Actavis Pharma, Inc. | 99a59495-2a48-4276-bbe3-cdd55a45aba4 | 2023-11-28 | Warnings, Adverse reactions | 0591-3509-04 0591-3509 00591350904 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.